Vol 46, No 1 (2015)
Prace poglądowe / Reviews
Published online: 2015-01-01
Personalized therapy for patients with follicular lymphoma in era of rituximab
DOI: 10.1016/j.achaem.2014.10.003
Acta Haematol Pol 2015;46(1):28-34.
Abstract
In patients with follicular lymphoma (FL), there are several factors influencing the disease course: morphological, immunological, genetic and clinical. The therapeutic options for patients with FL contain many methods such as rituximab with different chemotherapy regimens, radioimmunotherapy, radiotherapy and hematopoietic stem cell transplantation. The modern management of FL patients should consist of personalization of therapy related to risk factors.
Keywords: Follicular lymphomaRisk factorsPersonalized therapy
